A simple new way to detect disease using exosomes

Exosomes—tiny particles naturally released from cells—are gaining attention as powerful tools for diagnosing disease. These small extracellular vesicles carry molecular “fingerprints” from the cells they come from, making them ideal for identifying changes linked to illnesses like cancer or neurological disorders.

A new study by researchers from the University of Central Florida presents a rapid and efficient method for isolating and analyzing exosomes without the need for complicated labeling steps. The technique, called centrifugation-filtration-concentration (CFC), allows researchers to enrich exosomes up to 50-fold from cell culture media.

Instead of tagging exosomes with fluorescent or chemical labels, the researchers used simple, unlabeled antibodies that bind to proteins on the exosome surface. This binding causes the exosomes to clump together, which increases their average particle size. Using a technique called dynamic light scattering, scientists can measure this size increase and determine whether specific protein biomarkers are present.

In tests with three different types of cells—including brain tumor (GBM/NSC CD133+) cells—the researchers found that the method successfully detected exosome surface proteins by measuring the size changes. The test showed clear differences when the antibodies matched the exosomes versus when they didn’t, demonstrating its sensitivity and potential as a diagnostic tool.

This new approach could lead to faster and simpler ways to identify disease-specific extracellular vesicles in clinical samples, moving us closer to non-invasive, rapid diagnostics.